window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

early detection

  • Diagnostics,Gastroenterology,Genomics and sequencing,Partnerships & Funding,Technology and platforms

    Primerdesign and Origin partner on rectal mucus DNA extraction for colorectal cancer detection

    Primerdesign and Origin Sciences partner to develop a DNA extraction [...]

    March 25, 2026
  • Artificial Intelligence,Digital Health,Healthcare leadership,Medical devices,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    From awareness to action: Linus Health drives next era of early brain health detection

    Linus Health is accelerating its efforts in early brain health [...]

    January 19, 2026
  • Artificial Intelligence,Clinical Development,Clinical Trials,Digital Health,Neurosciences,Research & Development

    Linus Health to present AI-driven brain health research at CTAD 2025

    Linus Health, an AI-driven brain health company focused on early [...]

    November 20, 2025
  • Chronic diseases,Patient Centricity,Pharmaceuticals and therapeutics

    Every day is a balancing act: One Mum’s journey raising a daughter with Type 1 diabetes

    This is a disease awareness paid article sponsored by Sanofi. [...]

    November 13, 2025
  • Medical devices,Oncology,Patient Centricity,Regulatory Affairs

    Refold AI emerges to simplify enterprise integrations with agentic platform

    Mainz Biomed N.V., a molecular genetics diagnostic company specializing in [...]

    August 14, 2025
  • Clinical Development,Drug Development,Precision medicine,Research & Development,Technology and platforms

    AltPep data highlights potential of intranasal peptide for early-stage Alzheimer’s

    AltPep Corporation has presented new preclinical findings at the Alzheimer’s [...]

    July 28, 2025
  • Artificial Intelligence,Clinical Trials,Patient Centricity,Precision medicine,Technology and platforms

    Linus Health unveils AI-powered advances in early Alzheimer’s detection and personalized brain health at AAIC 2025

    Digital assessments designed to support earlier diagnosis, streamline Alzheimer’s trial [...]

    July 28, 2025
  • Artificial Intelligence,Drug Development,Patient Centricity,Technology and platforms

    Prenuvo research links alcohol and exercise to early brain and organ changes in asymptomatic adults

    Two new studies presented at the 2025 ISMRM Annual Meeting [...]

    June 27, 2025
  • Oncology

    Tagomics secures £860k Innovate UK grant to advance early detection of colorectal cancer

    Project aims to apply multiomic profiling for non-invasive diagnostic development [...]

    June 10, 2025
  • Partnerships & Funding,Patient Centricity

    New anthem shines light on Type 1 diabetes with support from Sanofi

    A new music initiative is raising awareness of autoimmune Type [...]

    May 29, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Symbiosis expands QC capabilities with new 30°C stability chamber
    Categories: CDMOs & Manufacturing, Facilities and infrastructure, Manufacturing, Pharmaceuticals and therapeutics
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top